123 related articles for article (PubMed ID: 8118553)
1. Extraction of Triton X-100 and its determination in virus-inactivated human plasma by the solvent--detergent method.
Strancar A; Raspor P; Schwinn H; Schütz R; Josic D
J Chromatogr A; 1994 Jan; 658(2):475-81. PubMed ID: 8118553
[TBL] [Abstract][Full Text] [Related]
2. Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Biologicals; 2007 Oct; 35(4):349-53. PubMed ID: 17656111
[TBL] [Abstract][Full Text] [Related]
3. Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system.
El-Ekiaby M; Sayed MA; Caron C; Burnouf S; El-Sharkawy N; Goubran H; Radosevich M; Goudemand J; Blum D; de Melo L; Soulié V; Adam J; Burnouf T
Transfus Med; 2010 Feb; 20(1):48-61. PubMed ID: 19778318
[TBL] [Abstract][Full Text] [Related]
4. Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents.
Burnouf T; Sayed MA; Radosevich M; El-Ekiaby M
Anal Biochem; 2009 Jun; 389(1):69-73. PubMed ID: 19303391
[TBL] [Abstract][Full Text] [Related]
5. Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII.
Roberts PL
Biologicals; 2008 Sep; 36(5):330-5. PubMed ID: 18674928
[TBL] [Abstract][Full Text] [Related]
6. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
[TBL] [Abstract][Full Text] [Related]
7. Removal of detergent and solvent from solvent-detergent-treated immunoglobulins.
Trescec A; Simić M; Branović K; Gebauer B; Benko B
J Chromatogr A; 1999 Aug; 852(1):87-91. PubMed ID: 10480233
[TBL] [Abstract][Full Text] [Related]
8. Determination of triton X-100 in plasma-derived coagulation factor VIII and factor IX products by reversed-phase high-performance liquid chromatography.
Karlsson G; Hinz AC; Henriksson E; Winge S
J Chromatogr A; 2002 Feb; 946(1-2):163-8. PubMed ID: 11873965
[TBL] [Abstract][Full Text] [Related]
9. Resistance of vaccinia virus to inactivation by solvent/detergent treatment of blood products.
Roberts P
Biologicals; 2000 Mar; 28(1):29-32. PubMed ID: 10799053
[TBL] [Abstract][Full Text] [Related]
10. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Transfusion; 2006 Dec; 46(12):2100-8. PubMed ID: 17176321
[TBL] [Abstract][Full Text] [Related]
11. Ion-exchange chromatography separation of the detergent and the solvent from immunoglobulins after solvent-detergent treatment.
Gebauer B; Simić M; Branović K; Trescec A; Benko B
J Chromatogr A; 1999 Aug; 852(1):83-6. PubMed ID: 10480232
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation.
Conley L; Tao Y; Henry A; Koepf E; Cecchini D; Pieracci J; Ghose S
Biotechnol Bioeng; 2017 Apr; 114(4):813-820. PubMed ID: 27800626
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary results of a prospective randomized clinical study on the comparison of solvent- and detergent-inactivated plasma (SDP-TNBT/Triton X-100) and untreated fresh-frozen plasma].
Mortelmans Y; Beck KH; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1994; 32():419-21. PubMed ID: 9480136
[TBL] [Abstract][Full Text] [Related]
14. Virus reduction in an intravenous immunoglobulin by solvent/detergent treatment, ion-exchange chromatography and terminal low pH incubation.
Roberts PL; Dunkerley C; Walker C
Biologicals; 2012 Sep; 40(5):345-52. PubMed ID: 22658506
[TBL] [Abstract][Full Text] [Related]
15. Manufacture and in vitro characterization of a solvent/detergent-treated human plasma.
Hellstern P; Sachse H; Schwinn H; Oberfrank K
Vox Sang; 1992; 63(3):178-85. PubMed ID: 1448962
[TBL] [Abstract][Full Text] [Related]
16. Dengue virus inactivation by minipool TnBP/Triton X-45 treatment of plasma and cryoprecipitate.
Burnouf T; Chou ML; Cheng LH; Li ZR; Wu YW; El-Ekiaby M; Tsai KH
Vox Sang; 2013 Jan; 104(1):1-6. PubMed ID: 22758375
[TBL] [Abstract][Full Text] [Related]
17. Virus inactivation in a factor VIII/VWF concentrate treated using a solvent/detergent procedure based on polysorbate 20.
Roberts PL; Lloyd D; Marshall PJ
Biologicals; 2009 Jan; 37(1):26-31. PubMed ID: 18848782
[TBL] [Abstract][Full Text] [Related]
18. Human platelet concentrates: a source of solvent/detergent-treated highly enriched brain-derived neurotrophic factor.
Burnouf T; Kuo YP; Blum D; Burnouf S; Su CY
Transfusion; 2012 Aug; 52(8):1721-8. PubMed ID: 22211513
[TBL] [Abstract][Full Text] [Related]
19. The removal of Triton X-100 by dialysis is feasible!
Opitz S; Hannika F; Krüger T; Rhode H
Anal Bioanal Chem; 2015 Feb; 407(4):1107-18. PubMed ID: 25424179
[TBL] [Abstract][Full Text] [Related]
20. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma.
Horowitz B; Bonomo R; Prince AM; Chin SN; Brotman B; Shulman RW
Blood; 1992 Feb; 79(3):826-31. PubMed ID: 1310064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
